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ABSTRACT
Regional lymph node metastases in colorectal cancer (CRC) decrease outcome. 
Whether nodal metastases function as a biomarker, i.e. as a sign of advanced disease, 
or are in fact involved in the metastatic process is unclear. We evaluated metastatic 
patterns of CRC according to the lymph node status of the primary tumor.
A retrospective review of 1393 patients with metastatic CRC who underwent 
autopsy in the Netherlands was performed. Metastatic patterns of regional lymph 
node positive and negative CRC were compared and validated by population-based 
data from the Eindhoven Cancer Registry (ECR).
Patients with regional lymph node positive CRC more often developed peritoneal 
metastases (28% vs. 21%, p=0.003) and distant lymph node metastases (25% vs. 
15%, p <0.001). Incidences of liver and lung metastases were comparable. Data from 
the ECR confirmed our findings regarding peritoneal (22.4% vs. 17.0%, p=0.003) and 
distant lymph node metastases (15.8% vs. 9.7%, p <0.001).
Regional lymph node positive CRC show a slightly different dissemination pattern, 
with higher rates of peritoneal and distant lymph nodes metastases. Comparable 
incidences of liver and lung metastases support the hypothesis that dissemination 
to distant organs occurs independently of lymphatic spread.
INTRODUCTION
Despite intensive follow-up and increasing 
therapeutic options for colorectal cancer (CRC), metastatic 
disease remains the leading factor in CRC mortality. 
CRC most frequently metastasizes to the liver, lung and 
peritoneum, but other metastatic sites such as bone, spleen, 
brain and distant lymph nodes have been described.[1-3] 
According to the mechanistical view of metastatic 
spread, tumor cells can disseminate to distant organs 
through two pathways: the vascular and the lymphatic 
pathway. The vascular hypothesis suggest that blood 
vessels transport tumor cells directly to distant organs. 
In the lymphatic pathway tumor cells may disseminate 
from regional lymph nodes to distant lymph nodes, reach 
the systemic circulation and subsequently form organ 
metastases.[4] The distinction between these pathways 
and their role in dissemination remains matter of debate. 
Post-mortem studies offer a possibility to register 
both the extent and location of metastatic disease. 
Findings during autopsy may be considered the ultimate 
endpoint of disease. Autopsy studies are therefore usefull 
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for getting insight in the relevance of lymphatic spread in 
the dissemination of cancer. Most autopsy studies, have 
focused on metastatic patterns in one or more types of 
cancer, but have failed to address differentiating aspects 
such as lymph node involvement. A large autopsy study by 
Budczies et al. across major cancer types, showed higher 
rates of metastases in distant lymph nodes, peritoneal 
cavity, pleura, pericardial and adrenal glands in lymph 
node positive tumors.[5] Although this study has given 
insight into metastatic patterns, this was done by grouping 
various cancers together. 
To gain insight in the relevance of lymphatic spread 
in the dissemination of CRC, we evaluated patterns of 
metastases according to the lymph node status of the 
primary tumor in 1393 autopsies. To confirm the clinical 
relevance, we analyzed population-based data from the 
Eindhoven Cancer Registry.
RESULTS
In the autopsy cohort, there were 1393 patients 
with metastatic disease; 879 patients (63%) with regional 
lymph node metastases (N+) and 514 patients (37%) 
without regional lymph node involvement (N-). The 
distribution of patient and tumor characteristics according 
Table 1: Distribution of tumor and patient characteristics according to 
regional lymph node status of the primary tumor in the autopsy cohort
Features N+ N- P-value
 879 (%) 514 (%)  
Gender 0.375
Male 514 58.5 313 60.9
Female 365 41.5 201 39.1
Age at diagnosis 0.681
<60 188 21.4 96 18.7
60-74 408 46.4 247 48.1
≥75 283 32.2 171 33.3
Location of primary 0.032
Proximal colon 337 38.3 162 31.5
Distal colon 271 30.8 162 31.5
Rectum 203 23.1 135 26.3
Colon, not specified 68 7.7 55 10.7
T Stage <0.001
T1 0 0 7 1.4
T2 37 4.2 53 10.3
T3 605 68.8 338 65.8
T4 193 22.0 101 19.6
Not specified 43 4.9 15 2.9
Histology 0.002
Non-mucinous       
  adenocarcinoma
 
695
 
79.1
 
441
 
85.8
Mucinous adenocarcinoma 156 17.7 68 13.2
Signet ring cell 28 3.2 5 1.0
Onset of metastases <0.001
Synchronous 538 61.2 186 36.2
Metachronous 341 38.8 328 63.8
Number of distant 
metastases <0.001
1 382 43.5 292 56.8
>1 497 56.5 222 43.2
N+: primary tumor with regional lymph node metastases;
N-: primary tumor without regional lymph node metastases.
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to regional lymph node status is presented in Table 1. N+ 
patients more often had a higher T-stage (T3/T4: 90.8% vs. 
85.4%, p<0.001), a tumor located in the proximal part of 
the colon (38.3% vs. 31.5%, p=0.01), mucinous or signet 
ring cell histology (20.9% vs. 14.2%, p=0.002), multiple 
metastases (56.5% vs. 43.2%, p<0.001) and synchronous 
onset of metastases (61.2% vs. 36.2%, p<0.001).
Distribution of metastases
The liver was the most frequent site of metastasis 
irrespective of regional lymph node status (68% in N+ 
and 67% in N-, p=0.53). Lung metastases occurred in 
33% of N- patients and in 35% of N+ patients (p=0.42; 
Figure 1a, supplementary Figure 1a). There was a higher 
rate of peritoneal metastases in N+ patients (28% vs. 
21%, p=0.003) and distant lymph node metastases were 
more often found in N+ patients (25% vs. 15%, p<0.001). 
Table 2: Distribution of tumor and patient characteristics according to 
regional lymph node status of the primary tumor in the clinical cohort
Features N+ N- P-value
 1711 (%) 671 (%)  
Gender 0.583
Male 952 55.6 365 54.4
Female 759 44.4 306 45.6
Age at diagnosis 0.008
<60 448 26.2 135 20.1
60-74 814 47.6 342 51.0
≥75 449 26.2 194 28.9
Location of primary 0.014
Proximal colon 609 35.6 192 28.6
Distal colon 504 29.5 216 32.2
Rectum 572 33.4 252 37.6
Colon, unknown 26 1.5 11 1.6
T Stage <0.001
T1 7 0.4 12 1.8
T2 83 4.8 89 13.3
T3 1101 64.4 411 61.2
T4 397 23.2 106 15.8
Unknown 123 7.2 53 7.9
Histology 0.230
Non-mucinous      
adenocarcinoma 1562 91.3 621 92.5
Mucinous adenocarcinoma 121 7.1 45 6.7
Signet ring cell 28 1.6 5 0.8
Onset of metastases <0.001
Synchronous 1155 67.5 318 47.4
Metachronous 556 32.5 353 52.6
Number of distant 
metastases <0.001
1 1067 62.4 460 68.6
>1 644 37.6 211 31.4
N-: primary tumor without regional lymph node metastases; 
N+: primary tumor with regional lymph node metastases
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Other significant differences were found for metastases in 
omentum, spleen and pancreas (N+ vs. N-; 9.2 vs. 3.3%, 
p<0.001, 2.8 vs. 1.0%, p=0.02, and 2.6 vs. 1.0%, p=0.04, 
respectively). 
When patients were subdivided according to the 
location of the primary tumor, a higher percentage of 
lung metastases in N+ rectal cancer as compared to N+ 
colon cancer (43.8% vs. 32.1%, p=0.001) and higher 
percentage of peritoneal metastases in N+ colon cancer as 
compared to N+ rectal cancer (30.8% vs. 19.2%, p=0.002) 
was found. This could be related to the higher overall 
percentage of lung metastases in rectal cancer compared 
with colon cancer (42.6% vs. 31.3%, p<0.001) and of 
peritoneal metastases in colon cancer compared with rectal 
cancer (28.1% vs. 17.2%, p<0.001). N+ colon cancers 
more often had peritoneal metastases and distant lymph 
node metastases compared with N- colon cancers (24.0% 
vs. 14.0%, p<0.001, and 30.8% vs. 23.2%, p=0.009, 
respectively). In rectal cancer only distant lymph node 
metastases were more often seen in N+ than in N- patients 
(28.1% vs. 18.5%, p=0.05).
Validation of findings
A total of 2382 patients with metastatic colorectal 
cancer from the Eindhoven Cancer Registry (ECR) was 
included, of which 1711 patients (71.8%) had regional 
lymph node metastases and 671 patients (28.2%) did not. 
Median follow-up was 5.0 years (range 1.2–8.8 years). 
The distribution of patient and tumor characteristics 
according to lymph node status is presented in Table 2. 
N+ patients more often developed peritoneal 
metastases and distant lymph node metastases (22.4% vs. 
17.0%, p=0.003, and 15.8% vs. 9.7%, p<0.001). Moreover, 
there was a higher percentage of liver metastases and 
a lower percentage of lung metastases in N+ patients 
compared with N- patients (71.6% vs. 66.3%, p=0.01 and 
Table 3: Risk of developing distant metastases in the clinical cohort
Clinicopathological 
factors
Risk of developing 
liver metastases
Risk of developing 
lung metastases
Risk of developing 
peritoneal 
carcinomatosis
Risk of developing distant 
lymph node metastases
MV analyses
OR (95% CI)
MV analyses
OR (95% CI)
MV analyses
OR (95% CI)
MV analyses
OR (95% CI)
Age
<59
60-74
≥75
1.00
0.99 (0.78-1.25)
0.96 (0.74-1.25)
1.00
1.26 (0.98-1.61)
1.13 (0.85-1.50)
1.00
0.85 (0.65-1.11)
0.98 (0.73-1.31)
1.00
0.87 (0.65-1.16)
0.67 (0.48-0.94)*
Gender
Male
Female
1.00
0.60 (0.50-0.72)***
1.00
1.02 (0.83-1.24)
1.00
1.19 (0.96-1.47)
1.00
1.15 (0.90-1.46)
Location of tumor
Proximal colon
Distal colon
Rectum
not specified
1.00
1.64 (1.30-2.08)***
1.33 (1.05-1.67)*
0.76 (0.37-1.54)
1.00
1.39 (1.06-1.81)*
2.25 (1.74-2.89)***
1.43 (0.63-3.23)
1.00
0.60 (0.47-0.76)***
0.24 (0.18-0.32)***
1.20 (0.59-2.46)
1.00
0.88 (0.65-1.20)
0.78 (0.58-1.06)
0.88 (0.35-2.23)
T-stage
T1-2
T3
T4
not specified
1.23 (0.86-1.76)
1.00
0.48 (0.38-0.61)***
1.14 (0.74-1.75)
1.00 (0.71-1.42)
1.00
1.10 (0.84-1.43)
1.32 (0.87-2.01)
0.42 (0.23-0.77)**
1.00
2.18 (1.72-2.77)***
1.26 (0.82-1.95)
1.17 (0.75-1.84)
1.00
1.28 (0.94-1.74)
3.76 (2.38-5.95)***
N-stage
N0
N1
N2
 
1.00
1.13 (0.90-1.41)
1.23 (0.95-1.58)
 
1.00
1.25 (0.99-1.59)
0.92 (0.70-1.22)
 
1.00
1.14 (0.87-1.49)
1.40 (1.05-1.87)*
 
1.00
1.97 (1.43-2.72)***
3.03 (2.14-4.29)***
Histology
Non-mucinous 
adenoca
Mucinous adenoca
 
1.00
0.46 (0.34-0.62)***
 
1.00
0.74 (0.52-1.05)
 
1.00
2.53 (1.84-3.47)***
 
1.00
1.20 (0.82-1.77)
Onset of metastases
Synchronous 
Metachronous
1.00
0.38 (0.31-0.47)***
1.00
4.10 (3.31-5.09)***
1.00
1.09 (0.86-1.37)
1.00
4.35 (3.31-5.71)***
In multivariate analyses adjustments were made for age, gender, location of the primary tumor, primary tumor stage, primary 
lymph node stage, tumor histology and onset of metastases. *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviations: MV: 
multivariate; OR: Odds Ratio; adenoca: adenocarcinoma.
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Figure  1: a. Distribution of CRC metastases according to regional lymph node status in the autopsy cohort. Left figure  shows the 
distribution of metastases for regional lymph node negative primary tumors, right figure  shows the distribution of metastases for regional 
lymph node positive primary tumors. * p = 0.003, ** p < 0.001. b. Distribution of CRC metastases according to distant lymph node 
positivity in the autopsy cohort. Left figure  shows the distribution of metastases for primary tumors without distant lymph node metastases, 
right figure  shows the distribution of metastases for primary tumors with distant lymph node metastases. * p < 0.001.
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23.7% vs. 27.7%, p=0.04, respectively).
Logistic regression analyses identified several 
clinicopathological factors that were associated with 
location specific metastases (Table 3). Rectal tumors 
were associated with a higher risk of developing liver 
and lung metastases (OR for liver: 1.33 (1.05-1.67), 
p<0.05, OR for lung: 2.25 (1.74-2.89), p<0.001), and 
with a lower risk of developing peritoneal carcinomatosis 
(OR: 0.24 (0.18-0.32), p<0.001). T4 tumors less often 
led to liver metastases (OR: 0.48 (0.38-0.61), p<0.001) 
and were associated with a higher risk of developing 
peritoneal carcinomatosis (OR: 2.18 (1.72-2.77), 
p<0.001). Lymph node positive tumors were associated 
with an increased risk of developing distant lymph node 
metastases, especially N2 tumors (OR: 3.03 (2.14-4.29), 
p<0.001). N2 tumors were also associated with peritoneal 
carcinomatosis (OR: 1.40 (1.05-1.87), p<0.05). Mucinous 
tumors less often led to liver metastases (OR: 0.46 (0.34-
0.62), p<0.001) and were associated with a higher risk of 
developing peritoneal carcinomatosis (OR: 2.53 (1.84-
3.47), p<0.001). 
Distant lymph node metastases
To provide further insight into the relevance of 
regional lymph node metastases for distant lymph node 
metastases, data was analyzed from 1024 cases with at 
least ten lymph nodes retrieved with the primary tumor. 
We found an increasing rate of distant lymph node 
metastases according to the number of positive lymph 
nodes detected in the primary tumor (Figure 2). Data 
from the ECR showed an increase from 9.1% in patients 
without positive lymph nodes to 27.1% in patients with 
more than twelve positive lymph nodes detected in the 
primary tumor (p<0.001). Data from the autopsy study 
showed an increase from 8.2% to 48.4% (p<0.001).
Compared with patients without distant lymph node 
metastases, patients with distant lymph node metastases 
more often had metastases in lung (57% vs. 29%, 
p<0.001), pleura (11% vs. 3%, p<0.001), bone (16% vs. 
4%, p<0.001), adrenal gland (16% vs. 5%, p<0.001) and 
kidney (7% vs. 2%, p<0.001) (Figure 1b, Supplementary 
Figure 1b). 
DISCUSSION
This is the first large study comparing metastatic 
patterns according to lymph node status of CRC. The 
most common site of distant metastasis was liver 
followed by lung, peritoneum and distant lymph nodes, 
with percentages comparable to literature.[2, 6] Peritoneal 
and distant lymph node metastases occurred more 
often in regional lymph node positive CRC, while liver 
and lung metastases occurred in a similar percentage. 
Our multivariate analysis shows that next to established 
risk factors for peritoneal carcinomatosis, like T-stage, 
proximal location and mucinous carcinoma, regional 
lymph node metastases are an important risk factor. This 
is in line with other studies[7-10] making it likely that 
lymph node metastases are involved in the etiology of 
peritoneal carcinomatosis. The omentum is a preferential 
site of peritoneal metastases and the lymphoid milky spots 
in the omentum are a homing site for metastatic cancer 
cells.[11] Tumor cells in the omentum can reach the 
peritoneal cavity by direct growth. The milky spots and 
the anti-inflammatory function of the omentum suggest a 
relation between the peritoneum and the lymphatic system. 
Moreover, chylous ascites can occur after obstruction or 
resection of extra-peritoneal located lymphatic vessels, 
providing more evidence for direct communications 
between lymphatic vessels and the peritoneal cavity.[12] 
The finding that regional lymph node positive CRC spread 
Figure  2: Percentage of patients with distant lymph node metastases according to the number of positive lymph nodes 
in primary tumor. Selection of patients with more than ten lymph nodes examined (N = 1024 pts; autopsy cohort = 258 pts; clinical 
cohort = 766 pts), p < 0.001.
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more often to distant lymph nodes is in line with others[5] 
and in support of the first part of the lymphatic hypothesis. 
However, since no difference was observed in liver 
metastases, the vascular hypothesis seems more important 
for liver metastases.[4] Based on the lymphatic hypothesis 
we expected that lymphatic drainage of the thoracic duct 
into the venous system would lead to a higher incidence 
of lung metastases in regional lymph node positive CRC. 
However, we found comparable incidences of lung 
metastases in the whole group of patients with regional 
lymph node positive CRC (n = 1590). In a subgroup of 
patients with distant lymph node metastases analysed in 
the autopsy cohort (n = 297), we did find increased lung 
and pleural metastases, suggesting that for this small 
subgroup the lymphatic pathway is important for the 
metastatic pattern. Our unique setup, where we validated 
findings from autopsy studies in a registry based cohort 
with prospectively collected data, illustrated only a 
limited influence of lymph node metastases on metastatic 
patterns in CRC. Autopsy studies contain selected 
populations, in which patients are included who have died 
postoperatively, had an unexpected clinical course, or died 
of other causes than CRC. Nevertheless, autopsy studies 
offer a unique opportunity to study the final distribution 
of metastases. During autopsy all intra-abdominal and 
intra-thoracic organs are extensively explored, revealing 
more metastases than would have been detected with 
imaging. This explains the high rate of distant lymph node 
metastases found in the autopsy cohort compared to the 
clinical cohort. 17% of cases (286/1679) in the autopsy 
cohort and 22% of cases (673/3092) in our clinical cohort 
had to be excluded because of non-documentation of the 
regional lymph node status, since there was no resection 
of the primary tumor. This might have caused bias in 
our patient selection. Moreover, there could have been 
variations in the quality of the autopsy examination and 
in the pathological examination of resected primary 
tumor specimens, which will have occurred in both 
groups. Therefore we do not expect a significant bias. 
We cannot exclude the possibility that changes in the 
management of colorectal cancer between 1991-2010, 
would have had an influence on the metastatic patterns 
established at autopsy. The introduction of radiotherapy, 
chemotherapy, targeted therapy and surgery of metastatic 
lesions, might have shifted the presence of metastases 
to more uncommon sites. However, our main findings 
were validated in the population study with a narrower 
time frame. This study shows that regional lymph node 
involvement in CRC is associated with a higher rate of 
peritoneal metastases and distant lymph node metastases. 
Our findings support the hypothesis that metastases to 
the liver and lung occur independently of lymphatic 
spread. Regional lymph node metastases function as a 
biomarker, i.e. as a sign of advanced disease, and seem 
only mechanisticly involved in the process of metastases 
in a small subgroup of patients with spread via the distant 
lymph nodes. Unfortunately, the presence of vascular 
invasion is grossly underreported in pathology reports, 
making a separate analysis for vascular invasion not 
possible. Therefore, our findings can only indirectly 
support the vascular pathway as a mechanism for 
development of common distant metastases, such as liver 
and lung metastases. However, the current recognition of 
extramural vascular invasion in the staging and treatment 
of colorectal cancer[13-15] seems justified.
MATERIALS AND METHODS
Study design
An autopsy cohort was selected to compare patterns 
of metastases according to the regional lymph node status 
of the primary tumor. Findings at autopsy are the ultimate 
endpoint of disease, making autopsy reports suitable 
for analyzing the extend of disease. Autopsy data are 
derived from a restricted patient population, therefore 
a prospectively collected cohort of the Eindhoven 
Cancer Registry (ECR) was chosen for validation. First, 
differences in metastatic pattern according to the lymph 
node status of the primary tumor were analysed. Due to 
the close relationship between lymphatic spread, regional 
and distant lymph node metastases, separate analyses were 
performed in tumors with and without distant lymph node 
metastases in the autopsy cohort. 
Autopsy cohort
A total of 1679 patients with metastatic colorectal 
cancer was identified in an autopsy study by Hugen et 
al.[16] Data from this study was used for the present 
analyses. Patients were selected from a retrospective 
review of pathological and autopsy records from 
the nationwide network and registry of histo- and 
cytopathology in the Netherlands (Pathologisch-
Anatomisch Landelijk Geautomatiseerd Archief; PALGA)
[17] Patients who were diagnosed with metastatic CRC 
and autopsied between 1991 and 2010 were selected. In 
the Netherlands post-mortem examination is performed 
at the request of the family or treating doctor and is 
carried out by a pathologist. All autopsies included in 
this study were performed in order to obtain information 
on the medical status of the deceased or to determine 
the exact cause of death. No forensic autopsies were 
included. Tumor histology was assessed by different 
pathologists. Local staging of the primary tumor was 
reconstructed according to the TNM classification (5th 
edition).[18] Allocation to the lymph node category 
was based on pathological examination of the original 
resection specimen or on the autopsy specimen. For 
regional lymph nodes metastasis only positive lymph 
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nodes along the colon or rectum, plus the nodes along the 
major arteries that supply blood to the colon or rectum 
were considered. Metastasis in all other nodes were 
considered distant lymph nodes metastases. Patients of 
whom the primary N-stage could not be retrieved were 
excluded (n=286). Colon tumors were classified as 
proximal if they were found in cecum, ascending colon 
or transverse colon, and classified as distal if they were 
found in the descending or sigmoid colon. Data on gender 
and age were available for all cases, but further clinical 
information (e.g. treatment or disease course) was lacking 
in this database and could not be retrieved. Metastatic 
disease was determined during pathological assessments 
of resected or biopsied specimens during follow-up or 
during autopsy. All metastases found at autopsy were 
histologically confirmed. Metastases that were detected 
more than six months after surgery of the primary tumor 
were considered metachronous.[19]
Clinical cohort
Data were retrieved from the Eindhoven Cancer 
Registry (ECR) which collects data of all patients with 
newly diagnosed cancer in the southeastern part of the 
Netherlands.[20] All patients who were diagnosed with 
CRC between 2003 and 2008 were included if they had 
synchronous metastases or developed metastases during 
follow-up untill 2010-2011 (n=3092). End of follow-up 
was defined as the date of death or end of data collection 
in 2010-2011. Patients who underwent an autopsy were 
excluded to prevent overlap with the initial cohort (n=37). 
Moreover, patients with missing N-stage (n=673) were 
excluded. Tumor staging, classification of primary tumor 
location and onset of metastatic disease were performed as 
described for the autopsy cohort. Allocation to the lymph 
node category was based on pathological examination 
of the original resection specimen. Anatomical sites of 
metastases were registered according to the International 
Classification of Diseases for Oncology (ICD-O).[21] 
Patterns of metastatic disease were determined based on 
the first site of metastasis. 
Statistical analysis
The χ² test was used to compare baseline 
characteristics between regional lymph node positive and 
negative CRC. Logistic regression analysis was used to 
analyze patient and tumor characteristics associated with 
location specific metastases. This analysis was performed 
in the clinical cohort, because of potential bias in the 
autopsy cohort. Odds ratio’s (ORs) were provided with 
their 95% confidence interval (CI). In multivariate (MV) 
analyses adjustments were made for age, gender, primary 
T-stage, primary N-stage, differentiation grade of primary 
tumor, localization of primary tumor, primary tumor 
histology and onset of metastases. Statistical analyses were 
performed using SAS/STAT1 statistical software (SAS 
system 9.3, SAS Institute, Cary, North Carolina, USA) 
and the statistical software package SPSS 20.0 (SPSS Inc, 
Chicago, Illinois, USA). All tests of significance were two 
sided and differences at P-values of ≤0.05 were considered 
to be significant.
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